Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
British Journal of Haematology
|
November 28, 2001
Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis
M Bornhäuser, M Kiehl, W Siegert, et al.
Deutsche Medizinische Wochenschrift (1946)
|
February 19, 2004
[Mobilization of stem cells by granulocyte colony-stimulating factor for the regeneration of myocardial tissue after myocardial infarction]
F Kuethe, H R Figulla, M Voth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group
C Kollmannsberger, O Rick, H-G Derigs, et al.
Bone Marrow Transplantation
|
December 24, 2013
Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial
M Koenigsmann, J Casper, C Kahl, et al.
Leukemia
|
November 28, 2002
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease
R Arnold, G Massenkeil, M Bornhäuser, et al.
Bone Marrow Transplantation
|
June 11, 2003
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor
H G Sayer, M Kröger, J Beyer, et al.
Leukemia
|
January 20, 2009
Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission
N Basara, A Schulze, U Wedding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2003
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group
J Schetelig, C Thiede, M Bornhauser, et al.
Journal of Cancer Research and Clinical Oncology
|
September 27, 2015
Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)
C Kahl, R Krahl, C Becker, et al.
Leukemia
|
October 3, 2003
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C
M C Müller, N Gattermann, T Lahaye, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
British Journal of Haematology
|
November 28, 2001
Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis
M Bornhäuser, M Kiehl, W Siegert, et al.
Deutsche Medizinische Wochenschrift (1946)
|
February 19, 2004
[Mobilization of stem cells by granulocyte colony-stimulating factor for the regeneration of myocardial tissue after myocardial infarction]
F Kuethe, H R Figulla, M Voth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group
C Kollmannsberger, O Rick, H-G Derigs, et al.
Bone Marrow Transplantation
|
December 24, 2013
Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial
M Koenigsmann, J Casper, C Kahl, et al.
Leukemia
|
November 28, 2002
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease
R Arnold, G Massenkeil, M Bornhäuser, et al.
Bone Marrow Transplantation
|
June 11, 2003
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor
H G Sayer, M Kröger, J Beyer, et al.
Leukemia
|
January 20, 2009
Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission
N Basara, A Schulze, U Wedding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2003
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group
J Schetelig, C Thiede, M Bornhauser, et al.
Journal of Cancer Research and Clinical Oncology
|
September 27, 2015
Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)
C Kahl, R Krahl, C Becker, et al.
Leukemia
|
October 3, 2003
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C
M C Müller, N Gattermann, T Lahaye, et al.
Page
of 5